Skip to content

Assessment of the Increased Risk of Infection Following an Ultratrail

Assessment of the Increased Risk of Infection Following an Ultratrail

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06089174
Acronym
INFultra
Enrollment
471
Registered
2023-10-18
Start date
2023-10-06
Completion date
2023-11-14
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Deficiency, Infections, Running

Keywords

Immune deficiency, Ultra-running, Infection

Brief summary

The increase in the practice of running has encouraged a proliferation of studies evaluating the impact of this sport on health. A number of these studies have looked at the influence of endurance events on the immune system. After prolonged exercise, a systemic inflammatory syndrome sets in, with repercussions for the functioning of the immune system. The number of lymphocytes in the blood is reduced, the function of natural killer (NK) cells is impaired and secretory immunity is impaired. During this period of immunosuppression, often referred to as the 'open window', the host may be more susceptible to micro-organisms that bypass the first line of defence. The invetigators' hypothesis is therefore that ultratrailers are overexposed to the risk of infection due to immunodepression resulting from practising this sport. In order to support this hypothesis, the investigators would like to look at infectious complications in general and ear-nose and throat episodes (rhinitis, pharyngitis, laryngitis, etc.) in particular, which are the most common infections encountered in primary care, along with urinary tract infections.

Interventions

OTHERUltra-trail

Questionnaires sent to runners at various pre-race and post-race times (Day3, Day6, Day10, Day14 and Day21)

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER
Jean Monnet University
CollaboratorOTHER
Hôpital Privé de la Loire- Saint Etienne
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

This study is a descriptive cohort study comparing the occurrence of infection between exposed (runners of an ultra-trail) and unexposed subjects (their companions).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \> 18 years * Participating in a Grand Raid de la Réunion 2023 race (Mascareignes, Trail de Bourbon, Diagonale des Fous) * Have a companion living under the same roof during the week preceding the race and the 21 days following the race and who agrees to answer the questionnaires * Do not object to the research

Exclusion criteria

* Do not understand French * A protected adult (guardianship or curatorship) or under court protection

Design outcomes

Primary

MeasureTime frameDescription
Increased risk of infectionDay 21Comparing the incidence of all infectious symptoms in runners taking part in one of the Grand Raid races (exposed subjects) with the incidence of infectious symptoms in those accompanying them on the race. fever, congestion, stuffy nose, sneezing, shortness of breath, vomiting, diarrhea, headache, sore throat, general fatigue, burning and urinary symptoms, other infectious symptoms; associated with major infections (respiratory, skin, gastrointestinal, urinary, other)

Secondary

MeasureTime frameDescription
Risk factors: training volumeDay 21Identify if the runner's training volume is a risk factor associated with the risk of infection in the 21 days following one of the Grand Raid de La Réunion races in runners (exposed subjects).
Kinetic of infections' appearanceDay 21Kinetics of the onset of infectious symptoms within 21 days following one of the Grand Raid de La Réunion races in runners (exposed subjects) and their companions (unexposed subjects). Survival curves over the 3 weeks post-race will be produced. An on-line questionnaire will be used to collect infectious data.
Risk factors: running distanceDay 21Identify if the distance of the race in which the runner participates is a risk factor associated with the risk of infection in the 21 days following one of the Grand Raid de La Réunion races in runners (exposed subjects). An on-line questionnaire will be used to collect data related to the race distance.
Risk factors: sex of the runnerDay 21Identify if sex of the runner is a risk factor associated with the risk of infection in the 21 days following one of the Grand Raid de La Réunion races in runners (exposed subjects).
Risk factors: age categoryDay 21Identify if the age of the runner is a risk factor associated with the risk of infection in the 21 days following one of the Grand Raid de La Réunion races in runners (exposed subjects).

Countries

Reunion

Contacts

PRINCIPAL_INVESTIGATORNicolas BOUSCAREN, MD

CHU de la Réunion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026